202 related articles for article (PubMed ID: 22496331)
1. Emerging anti-inflammatory strategies for COPD.
Cazzola M; Page CP; Calzetta L; Matera MG
Eur Respir J; 2012 Sep; 40(3):724-41. PubMed ID: 22496331
[TBL] [Abstract][Full Text] [Related]
2. Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development.
Fitzgerald MF; Fox JC
Drug Discov Today; 2007 Jun; 12(11-12):479-86. PubMed ID: 17532533
[TBL] [Abstract][Full Text] [Related]
3. Systemic manifestations and comorbidities of COPD.
Barnes PJ; Celli BR
Eur Respir J; 2009 May; 33(5):1165-85. PubMed ID: 19407051
[TBL] [Abstract][Full Text] [Related]
4. New concepts in chronic obstructive pulmonary disease.
Barnes PJ
Annu Rev Med; 2003; 54():113-29. PubMed ID: 12359824
[TBL] [Abstract][Full Text] [Related]
5. New therapies for chronic obstructive pulmonary disease.
Barnes PJ
Med Princ Pract; 2010; 19(5):330-8. PubMed ID: 20639653
[TBL] [Abstract][Full Text] [Related]
6. New treatments for chronic obstructive pulmonary disease.
Barnes PJ
Ann Ist Super Sanita; 2003; 39(4):573-82. PubMed ID: 15098577
[TBL] [Abstract][Full Text] [Related]
7. The role of animal models in the pharmacological evaluation of emerging anti-inflammatory agents for the treatment of COPD.
Fox JC; Fitzgerald MF
Curr Opin Pharmacol; 2009 Jun; 9(3):231-42. PubMed ID: 19356979
[TBL] [Abstract][Full Text] [Related]
8. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease.
Donnelly LE; Barnes PJ
Trends Pharmacol Sci; 2006 Oct; 27(10):546-53. PubMed ID: 16911834
[TBL] [Abstract][Full Text] [Related]
9. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
Onoue S; Misaka S; Kawabata Y; Yamada S
Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
[TBL] [Abstract][Full Text] [Related]
10. Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD.
Morjaria JB; Malerba M; Polosa R
Drug Discov Today; 2010 May; 15(9-10):396-405. PubMed ID: 20223295
[TBL] [Abstract][Full Text] [Related]
11. Regulation of inflammatory cell function by corticosteroids.
Belvisi MG
Proc Am Thorac Soc; 2004; 1(3):207-14. PubMed ID: 16113436
[TBL] [Abstract][Full Text] [Related]
12. The cytokine network in chronic obstructive pulmonary disease.
Barnes PJ
Am J Respir Cell Mol Biol; 2009 Dec; 41(6):631-8. PubMed ID: 19717810
[TBL] [Abstract][Full Text] [Related]
13. Role of transcription factors in the pathogenesis of asthma and COPD.
Caramori G; Casolari P; Adcock I
Cell Commun Adhes; 2013 Feb; 20(1-2):21-40. PubMed ID: 23472830
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations.
Tsoumakidou M; Siafakas NM
Respir Res; 2006 May; 7(1):80. PubMed ID: 16716229
[TBL] [Abstract][Full Text] [Related]
15. Mediators of chronic obstructive pulmonary disease.
Barnes PJ
Pharmacol Rev; 2004 Dec; 56(4):515-48. PubMed ID: 15602009
[TBL] [Abstract][Full Text] [Related]
16. Chronic obstructive pulmonary disease: histopathology, inflammation and potential therapies.
Molfino NA; Jeffery PK
Pulm Pharmacol Ther; 2007; 20(5):462-72. PubMed ID: 16798034
[TBL] [Abstract][Full Text] [Related]
17. Steroid-resistant inflammation in a rat model of chronic obstructive pulmonary disease is associated with a lack of nuclear factor-kappaB pathway activation.
Birrell MA; Wong S; Hele DJ; McCluskie K; Hardaker E; Belvisi MG
Am J Respir Crit Care Med; 2005 Jul; 172(1):74-84. PubMed ID: 15805185
[TBL] [Abstract][Full Text] [Related]
18. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications.
Tamimi A; Serdarevic D; Hanania NA
Respir Med; 2012 Mar; 106(3):319-28. PubMed ID: 22196881
[TBL] [Abstract][Full Text] [Related]
19. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.
Hattotuwa KL; Gizycki MJ; Ansari TW; Jeffery PK; Barnes NC
Am J Respir Crit Care Med; 2002 Jun; 165(12):1592-6. PubMed ID: 12070058
[TBL] [Abstract][Full Text] [Related]
20. Cells, mediators and Toll-like receptors in COPD.
Sarir H; Henricks PA; van Houwelingen AH; Nijkamp FP; Folkerts G
Eur J Pharmacol; 2008 May; 585(2-3):346-53. PubMed ID: 18410916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
